Regulators OK expanded Crestor useThe Food and Drug Administration decision will allow the …
Study: 'E- cigarettes' don't deliverThe latest clinical evidence suggests users are not getting the…
Ag Sec'y pushes school nutrition planChild nutrition and obesity have emerged as key issues for the …
Discarded meds found in landfill watersA study in Maine shows that unused or expired medications that …
Another Diabetes drug appears to work
Updated: Tuesday, 31 Mar 2009, 11:18 AM EDT
Published : Tuesday, 31 Mar 2009, 11:18 AM EDT
Federal health officials say a potential blockbuster diabetes drug from Novo Nordisk appears to work.
But it says questions remain about its effect on the heart and other organs.
Results from the drugmaker show liraglutide helps control blood sugar when used alone or with other medications.
But regulators have concerns about heart problems and thyroid tumors seen in some company studies.
Novo Nordisk is hoping its once-a-day injection can take sales away from Byetta, a twice-a-day injection from Eli Lilly and Amylin Pharmaceuticals that works similarly.
The FDA meets with its outside diabetes experts this week to review liraglutide and another drug looking to compete in the expanding $5.1 billion U.S. market for diabetes drugs.
Ground rules for posting comments: No profanity or personal attacks. Please comment on the subject of the story itself. If you do not follow these rules, we will remove your post. We reserve the right to refuse to post or to remove any information or materials, in whole or in part, that in our sole discretion are objectionable or in violation of our Terms of Service.
Email This
PrintThis
View Story on a Single Page
Credit card laws take effect this month
The holidays are over and the only presents in the mail are those nagging credit…